Wednesday, April 13th, 2016 - China Market Research Reports

Peripheral neuropathy is a syndrome, which is a single or any combination form of sensory loss, muscle weakness and atrophy, decreased tendon reflex and vasomotion symptoms. The factors which lead to peripheral neuropathy are that the damage of single neural limitation is a common cause of trauma, while multiple single neuropathy occurs secondary to collagen vascular disease; Multiple neuropathy may be caused by toxins, toxic substances, nutrition deficiency, metabolic disease and malignant tumors.

Complete Report Available @ http://www.chinamarketresearchreports.com/115314.html

Methylcobalamin, derivative of Vitamin B12, is active Vitamin B12 and the therapeutic drug of peripheral neuropathy. It can promote intraneural nucleic acid, protein and metabolism, facilitate the synthesis of DNA,RNA as well as the synthesis of lecithin lipid, which is the main component of myelin sheath, and accelerate to restore the damaged nerve tissue to improve the transformation of nerve tissue and the disturbance of metabolism. In addition, it also works on restraining unusual exciting conduction of nerve tissue. Methylcobalamin,. whose trade name is mecobalamin, was developed by Eisai Co., Ltd. and put in the market in Japan in the middle of 1980s.In 1996, mecobalamin entered the Chinese market.

Inquire for Discount @ http://www.chinamarketresearchreports.com/contacts/inquiry.php?name=115314

Methylcobalamin developed rapidly after entering China. Its annual sales value increased from less than 200 million CNY in 2005 to 441 million CNY in 2014, with CAGR of 12.32%. It had broad market demand in China. Eisai (Suzhou) Pharmaceutical Co., Ltd, Eisai Co., Ltd. (Japan), Jiangsu Sihuan Bioengineering Co., Ltd, Nanjing Hailing Pharmaceutical Co., Ltd. and NCPC occupy large market share, among which Eisai (Suzhou) Pharmaceutical Co., Ltd occupies most, whose annual market share of sales value was over 40% in 2014. It is predicted that in next few years, the incidence of peripheral neuropathy in China will gradually rise, making the market scale of methylcobalamin continue to increase.

List of Charts

Chart Patent Status of Methylcobalamin in China 
Chart Approval Information of Methylcobalamin in China
Chart Sales Status of Methylcobalamin in China 
Chart Sales Value of Methylcobalamin in China, 2010-2014 
Chart Sales Value of Methylcobalamin in Some Regions of China, 2010-2014
Chart Sales Volume of Methylcobalamin in China, 2010-2014
Chart Sales Volume of Methylcobalamin in Some Regions of China, 2010-2014
Market Share of Corporations of TOP5 Methylcobalamin Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Eisai (Suzhou) in China, 2010-2014 
Chart Sales Value and Market Share of Methylcobalamin Produced by Eisai (Japan) in China, 2010-2014 
Chart Sales Value and Market Share of Methylcobalamin Produced by Jiangsu Sihuan in China, 2010-2014 
Chart Sales Value and Market Share of Methylcobalamin Produced by Nanjing Hailing in China, 2010-2014 
Chart Sales Value and Market Share of Methylcobalamin Produced by NCPC in China, 2010-2014 
Chart Sales Value and Market Share of Methylcobalamin Injection in China, 2010-2014 
Chart Sales Value and Market Share of Methylcobalamin Tablet in China, 2010-2014 
Chart Sales Value and Market Share of Methylcobalamin Capsule in China, 2010-2014 
Chart Sales Price of Methylcobalamin Produced by NCPC in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Eisai (Suzhou) in Some Chinese Cities in 2014 
Chart Sales Price of Methylcobalamin Produced by Eisai (Japan) in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Nanjing Hailing Pharmaceutical Co., Ltd. in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Jiangsu Sihuan Bioengineering Co., Ltd. in Some Chinese Cities in 2014

Order a copy of this report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=115314

Contact Profile

China Market Research Reports


China market research reports portal aims at providing business intelligence, market research, company research, investment consultation and other market intelligence data for multiple industries in China. The reports available through our website are from publishers that focus on meeting research and information requirements of corporate, businesses, institutions, and global professional investors for IPO, corporate mergers and acquisition, business development, market launch, financing and more. These China reports are helpful for strategic formulation, forecasting, risk management, and investment research with all the available data and information analysis, saving time and money for businesses and clients. Feel free to get in touch with us ([email protected] / +1 888 391 5441) with your specific requirements, topics of interest or anything that you are not able to find on our portal.


Ritesh Tiwari
P: + 1 888 391 5441
W: www.chinamarketresearchreports.com/

Keywords

Methylcobalamin, Methylcobalamin market, Methylcobalamin industry, china Methylcobalamin market, china Methylcobalamin industry, market trends of Methylcobalamin

Categories

Newsrooms

Sharing

More Formats